Literature DB >> 32939924

National variations in perioperative assessment and surgical management of Crohn's disease: a multicentre study.

.   

Abstract

AIM: Crohn's disease (CD) requires a multidisciplinary approach and surgery should be undertaken by dedicated colorectal surgeons with audited outcomes. We present a national, multicentre study, with the aim to collect benchmark data on key performance indicators in CD surgery, to highlight areas where standards of CD surgery excel and to facilitate targeted quality improvement where indicated.
METHODS: All patients undergoing ileocaecal or redo ileocolic resection in the participating centres for primary and recurrent CD from June 2018 to May 2019 were included. The main objective was to collect national data on hospital volume and practice variations. Postoperative morbidity was the primary outcome. Laparoscopic surgery and stoma rate were the secondary outcomes.
RESULTS: In all, 715 patients were included: 457 primary CD and 258 recurrent CD with a postoperative morbidity of 21.6% and 34.7%, respectively. Laparoscopy was used in 83.8% of primary CD compared to 31% of recurrent CD. Twenty-five hospitals participated and the total number of patients per hospital ranged from 2 to 169. Hospitals performing more than 10 primary CD procedures per year showed a higher adoption of laparoscopy and bowel sparing surgery.
CONCLUSIONS: There is significant heterogeneity in the number of CD surgeries performed per year nationally in Italy. Our data suggest that high-volume hospitals perform more complex procedures, with a higher adoption of bowel sparing surgery. The rate of laparoscopy in high-volume hospitals is higher for primary CD but not for recurrent CD compared with low-volume hospitals.
© 2020 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Crohn's disease; colorectal surgery; ileocaecal resection; inflammatory bowel disease; national audit

Year:  2020        PMID: 32939924     DOI: 10.1111/codi.15334

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

Review 1.  Surgical Techniques and Risk of Postoperative Recurrence in CD: A Game Changer?

Authors:  Gaetano Luglio; Toru Kono
Journal:  Inflamm Intest Dis       Date:  2021-05-21

2.  The safety and feasibility of laparoscopic redo surgery for recurrent Crohn's disease: A comparative clinical study of over 100 consecutive patients.

Authors:  Takayuki Ogino; Yuki Sekido; Tsuyoshi Hata; Norikatsu Miyoshi; Hidekazu Takahashi; Mamoru Uemura; Hirofumi Yamamoto; Yuichiro Doki; Hidetoshi Eguchi; Tsunekazu Mizushima
Journal:  Ann Gastroenterol Surg       Date:  2021-12-16

Review 3.  The Role of Inflammation in Crohn's Disease Recurrence after Surgical Treatment.

Authors:  B Sensi; L Siragusa; C Efrati; L Petagna; M Franceschilli; V Bellato; A Antonelli; C Arcudi; M Campanelli; S Ingallinella; A M Guida; A Divizia
Journal:  J Immunol Res       Date:  2020-12-26       Impact factor: 4.818

4.  Single-incision laparoscopic surgery (SILS) for the treatment of ileocolonic Crohn's disease: a propensity score-matched analysis.

Authors:  Valerio Celentano; Gianluca Pellino; Matteo Rottoli; Francesco Colombo; Gianluca Sampietro; Antonino Spinelli; Francesco Selvaggi
Journal:  Int J Colorectal Dis       Date:  2020-12-23       Impact factor: 2.571

5.  The INTESTINE study: INtended TEmporary STomas In crohN's diseasE. Protocol for an international multicentre study.

Authors:  Valerio Celentano; Claire Perrott; Patricia Tejedor; Giacomo Calini; Matteo Rottoli; Christos Kontovounisios; Paris Tekkis
Journal:  Updates Surg       Date:  2022-08-12

6.  Surgical management of complex ileocolonic Crohn's disease: a survey of IBD colorectal surgeons to assess variability in operative strategy.

Authors:  E Garofalo; F Selvaggi; A Spinelli; G Pellino; K Flashman; M Frasson; M Carvello; N de'Angelis; A Garcia-Granero; M Harper; J Warusavitarne; M Coleman; E Espin; V Celentano
Journal:  Int J Colorectal Dis       Date:  2021-02-25       Impact factor: 2.796

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.